Research news
- 20 October 2011
European Court bans patents on embryonic stem cells The European Court of Justice has made the decision to ban the patenting of scientific techniques involving embryonic stem cells. - 20 October 2011
Research-focused amendments to the Health and Social Care Bill The Muscular Dystrophy Campaign is voicing its support of the proposed research-focused amendments to the Health and Social Care Bill as it enters the Committee Stage in the House of Lords. - 18 October 2011
Nine cutting-edge new research projects awarded funding We are proud to announce the addition of nine exciting new projects to our portfolio which aim to increase understanding of and develop treatments for muscle diseases. - 6 October 2011
Clinical trial being planned for congenital muscular dystrophy A clinical trial to test a drug called omigapil in Ullrich congenital muscular dystrophy, Bethlem myopathy and merosin-deficient congenital muscular dystrophy (MDC1A) is being planned for 2012. - 6 October 2011
Have your say about medical research A study is asking people aged 12 to 21 who have muscular dystrophy about their attitudes towards medical research and taking part in it. - 16 September 2011
Update on our cutting edge FSH research The research team and two members of our Lay Panel recently visited Dr Peter Zammit's laboratory for an update on their research into facioscapulohumeral muscular dystrophy. - 13 September 2011
Prosensa moves three more molecular patches for Duchenne forward Prosensa announced today that they have reached an agreement with GSK to take three more molecular patches to the next development stage - 9 September 2011
PTC Therapeutics to take over development of ataluren for Duchenne Genzyme and PTC Therapeutics have restructured their collaboration for the development of the drug ataluren for Duchenne muscular dystrophy. - 25 August 2011
Two research teams make steps towards a treatment for FSH Researchers have successfully used a gene therapy approach to reverse the symptoms of facioscapulohumeral muscular dystrophy in a mouse model, a technique that could also be applied to other muscle conditions. - 17 August 2011
Next phase of Duchenne exon skipping clinical trials started AVI Biopharma has announced that they have started the clinical trial in the US to test higher doses of the exon skipping drug.
